ACTIVE_NOT_RECRUITING

Feasibility and Acceptability of Incorporating Smartwatches Into an Exercise is Medicine Program in Older Individuals

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The effects of exercise on prevention and improved control of chronic diseases, reduced mortality, and improved quality of life are well established. Exercise has been shown to prevent heart disease, stroke, type 2 diabetes, depression, and certain types of cancers. In addition to prevention, physical activity is included in the standard or care for many chronic diseases and used in treatment. For example, the American Diabetes Association has identified positive health behaviors like physical activity as foundational in the treatment and management of disease and improving overall quality of life. The Ohio State University Wexner Medical Center Exercise is Medicine Program (EIM) is a physician referral program that aims to increase physical activity to prevent and reduce complications from chronic disease. The integration of technology among a 65+ population of EIM participants provides a novel approach to improving individual's health. Thus, our study aims to provide EIM participants aged 65+ with smartwatches in the hopes of increasing their overall physical activity levels.

Official Title

Feasibility and Acceptability of Incorporating Fitbit Smartwatches Into a Health System Referral Based Exercise is Medicine Program in Older Individuals (EIM+)

Quick Facts

Study Start:2024-03-15
Study Completion:2026-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06287255

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 65+
  2. * No healthcare provider-imposed limitations on physical activity
  3. * English-speaking
  1. * Symptoms suggestive of coronary artery disease (CAD) or congestive heart failure (CHF) (i.e. chest pain, dizziness, syncope, excessive dyspnea on exertion)
  2. * Myocardial infarction within the last 12 months
  3. * Revascularization within the last 12 months
  4. * Stroke/transient ischemic attack (TIA) within the past 12 months
  5. * Unstable angina
  6. * Congestive heart failure (New York Heart Association (NYHA) Class II, III or IV)
  7. * Ventricular arrhythmia
  8. * Clinically significant cardiac valve disease
  9. * Blood pressure \>160/100 mmHg
  10. * Uncontrolled seizure disorder
  11. * Major surgery within the past three months
  12. * Severe or frequent hypoglycemia
  13. * Inability to independently manage blood glucose during activity
  14. * Severe autonomic or peripheral neuropathy
  15. * Active foot ulcers
  16. * Unstable retinopathy.

Contacts and Locations

Principal Investigator

Joshua Joseph, MD
PRINCIPAL_INVESTIGATOR
Ohio State University

Study Locations (Sites)

The Ohio State University
Columbus, Ohio, 43202
United States

Collaborators and Investigators

Sponsor: Ohio State University

  • Joshua Joseph, MD, PRINCIPAL_INVESTIGATOR, Ohio State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-15
Study Completion Date2026-05-01

Study Record Updates

Study Start Date2024-03-15
Study Completion Date2026-05-01

Terms related to this study

Additional Relevant MeSH Terms

  • Physical Inactivity
  • Obesity